Literature DB >> 19803750

Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience.

Hans O Hallander, Lennart Gustafsson.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19803750     DOI： 10.1586/erv.09.88

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  11 in total

Review 1.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

2.  The Swiss National Vaccination Coverage Survey, 2005-2007.

Authors:  Phung Lang; Hanspeter Zimmermann; Ursula Piller; Robert Steffen; Christoph Hatz
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

Review 3.  Licensed pertussis vaccines in the United States. History and current state.

Authors:  Nicola P Klein
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

4.  Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain).

Authors:  P Plans; D Toledo; M R Sala; N Camps; M Villanova; R Rodríguez; J Alvarez; R Solano; M García-Cenoz; I Barrabeig; P Godoy; S Minguell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-09       Impact factor: 3.267

Review 5.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

Review 6.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.

Authors:  Marie-Louise von Linstow; Peter Lotko Pontoppidan; Carl-Heinz Wirsing von König; James D Cherry; Birthe Hogh
Journal:  Eur J Pediatr       Date:  2010-04-08       Impact factor: 3.183

Review 8.  Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.

Authors:  Vincenzo Baldo; Paolo Bonanni; Marcela Castro; Giovanni Gabutti; Elisabetta Franco; Federico Marchetti; Rosa Prato; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2013-09-04       Impact factor: 3.452

9.  Prevention of pertussis: from clinical trials to Real World Evidence.

Authors:  S Esposito
Journal:  J Prev Med Hyg       Date:  2018-09-28

Review 10.  Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.

Authors:  Susanna Esposito; Paola Stefanelli; Norman K Fry; Giorgio Fedele; Qiushui He; Pauline Paterson; Tina Tan; Markus Knuf; Carlos Rodrigo; Catherine Weil Olivier; Katie L Flanagan; Ivan Hung; Iria Lutsar; Kathryn Edwards; Miguel O'Ryan; Nicola Principi
Journal:  Front Immunol       Date:  2019-07-03       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.